NPR

New Type Of Drug To Prevent Migraines Heads To Market

An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.

The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines among people prone to these sometimes crippling headaches.

That's welcome news to some of the millions of Americans who suffer from these . Much more common in women than

You're reading a preview, sign up to read more.

More from NPR

NPR6 min read
A Pop Cyborg With A Human Heart
As the voice of Chairlift, Caroline Polachek crisscrossed indie and mainstream tastes. Her solo LP adds digital flex to that voice, melding real and "enhanced" performance into one penetrating force.
NPR3 min read
Mattis Takes Swipe At Trump: 'I Earned My Spurs On The Battlefield'
In a speech blending humor with a serious message, the former secretary of defense also quoted a warning by Lincoln against a leader "unfettered by conscience, precedent or decency."
NPR4 min read
A Daughter Becomes An Accomplice To Her Mother's Affair In 'Wild Game'
As a teen, Adrienne Brodeur helped her mother keep a long-term affair a secret. In her memoir, she writes of realizing that being her mother's confidant didn't equal the unconditional love she sought.